(Sharecast News) - Novartis returned to sales growth in the second quarter, it announced on Tuesday, as demand for newer medicines helped offset intensifying generic competition for former blockbuster Entresto.
Net sales rose 1% at constant currencies to $14.41bn, while core operating profit was flat at $5.94bn, ahead of market forecasts,...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE